The Role of Punicalagin and Its Metabolites in Atherosclerosis and Risk Factors Associated with the Disease
Atherosclerotic cardiovascular disease (ACVD) is the leading cause of death worldwide. Although current therapies, such as statins, have led to a marked reduction in morbidity and mortality from ACVD, they are associated with considerable residual risk for the disease together with various adverse s...
Main Authors: | Sulaiman Alalawi, Faizah Albalawi, Dipak P. Ramji |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/10/8476 |
Similar Items
-
Punicalagin Regulates Key Processes Associated with Atherosclerosis in THP-1 Cellular Model
by: Sanaa Almowallad, et al.
Published: (2020-11-01) -
Punicalagin Targets Atherosclerosis: Gene Expression Profiling of THP-1 Macrophages Treated with Punicalagin and Molecular Docking
by: Etimad Huwait, et al.
Published: (2022-05-01) -
Punicalagin Regulates Signaling Pathways in Inflammation-Associated Chronic Diseases
by: Jie Xu, et al.
Published: (2021-12-01) -
Punicalagin Protects against the Development of Methotrexate-Induced Hepatotoxicity in Mice via Activating Nrf2 Signaling and Decreasing Oxidative Stress, Inflammation, and Cell Death
by: Alayn’ Al-marddyah A. Al-khawalde, et al.
Published: (2022-10-01) -
Oral Supplement Containing Hydroxytyrosol and Punicalagin Improves Dyslipidemia in an Adult Population without Co-Adjuvant Treatment: A Randomized, Double-Blind, Controlled and Crossover Trial
by: Rebeca Quirós-Fernández, et al.
Published: (2022-04-01)